Arrhythmias & electrophysiologyTrial design
Study protocol for The Heart Watch Study - Prognostic performance of smartwatch 12-lead electrocardiography (ECG) with advanced ECG analysis in consumer self-screening for cardiovascular disease
- prospective, Australia-wide observational cohort study
- study protocol
Study context
- Population
- Asymptomatic adults aged 20–79 years without prior known cardiovascular disease performing consumer self-screening in the general populationplanned recruitment
- Participants
- 30,000 adults
- Planned comparison
- Advanced ECG (A-ECG) analysis applied to a smartwatch 12-lead ECG (SWECG) acquired using an Apple Watch in identifying cardiovascular risks
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Study protocol for The Heart Watch Study - Prognostic performance of smartwatch 12-lead ECG with advanced ECG analysis in consumer self-screening for cardiovascular disease. Am Heart J. Published 29 September 2026. doi:10.1016/j.ahj.2026.107619
Summarised from the published abstract; every number is checked against it